Evidence map›Paper›PMID 34301328›Full record

ArticleBMC research notes2021

An exploratory assessment of the applicability of direct-to-consumer genetic testing to translational research in Japan.

Masahiro Inoue, Shota Arichi, Tsuyoshi Hachiya, Anna Ohtera, Seok-Won Kim, Eric Yu, Masatoshi Nishimura, Kazuhito Shiosakai, Takeshi Ohira

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Masahiro InoueHealthData Lab, Yahoo! Japan Corporation, Kioi Tower, Tokyo Garden Terrace Kioicho, 1-3, Kioi-cho, Chiyoda-ku, Tokyo, 102-8282, Japan.
Shota ArichiHealthData Lab, Yahoo! Japan Corporation, Kioi Tower, Tokyo Garden Terrace Kioicho, 1-3, Kioi-cho, Chiyoda-ku, Tokyo, 102-8282, Japan.
Tsuyoshi HachiyaHealthData Lab, Yahoo! Japan Corporation, Kioi Tower, Tokyo Garden Terrace Kioicho, 1-3, Kioi-cho, Chiyoda-ku, Tokyo, 102-8282, Japan.
Anna OhteraReal World Evidence Solutions, IQVIA Solutions Japan K.K, Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan.
Seok-Won KimReal World Evidence Solutions, IQVIA Solutions Japan K.K, Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan.
Eric YuReal World Evidence Solutions, IQVIA Solutions Japan K.K, Takanawa 4-10-18, Minato-ku, Tokyo, 108-0074, Japan.
Masatoshi NishimuraDaiichi Sankyo Co. Ltd, Tokyo, Japan.
Kazuhito ShiosakaiDaiichi Sankyo Co. Ltd, Tokyo, Japan.
Takeshi OhiraDaiichi Sankyo Co. Ltd, Tokyo, Japan. ohira.takeshi.cy@daiichisankyo.co.jp.
Daiichi-Sankyo (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn order to assess the applicability of a direct-to-consumer (DTC) genetic testing to translational research for obtaining new knowledge on relationships between drug target genes and diseases, we examined possibility of these data by associating SNPs and disease related phenotype information collected from healthy individuals.

resultsA total of 12,598 saliva samples were collected from the customers of commercial service for SNPs analysis and web survey were conducted to collect phenotype information. The collected dataset revealed similarity to the Japanese data but distinguished differences to other populations of all dataset of the 1000 Genomes Project. After confirmation of a well-known relationship between ALDH2 and alcohol-sensitivity, Phenome-Wide Association Study (PheWAS) was performed to find association between pre-selected drug target genes and all the phenotypes. Association was found between GRIN2B and multiple phenotypes related to depression, which is considered reliable based on previous reports on the biological function of GRIN2B protein and its relationship with depression. These results suggest possibility of using SNPs and phenotype information collected from healthy individuals as a translational research tool for drug discovery to find relationship between a gene and a disease if it is possible to extract individuals in pre-disease states by properly designed questionnaire.

Indexed as

Direct-To-Consumer Screening and TestingGenetic TestingGenome-Wide Association StudyTranslational Research, BiomedicalAldehyde Dehydrogenase, MitochondrialHumansJapanPhenotypePolymorphism, Single NucleotideReceptors, N-Methyl-D-AspartateAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanNR2B NMDA receptorReceptors, N-Methyl-D-AspartateDTCGRIN2BPhenotypePheWASSNPsTranslational research

Identifiers

PMID34301328
PMCPMC8305957
OpenAlexW3184333073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.